Catherine Skari

EdiGene Announces Approval in China of its IND Application for CRISPR/Cas 9 Gene Editing Therapy ET-01 in β-thalassaemia

The Center for Drug Evaluation (CDE) of China‘s National Medical Products Administration (NMPA) has recently approved EdiGene’s application for ET-01, an…

Read More »

The New Issue of the TIF Newsletter Is Just Released

Read More »

TIF Newsletter – December 2020

Read More »

Just Updated: TIF’s Vaccinations & Therapeutic Drugs for COVID-19 Guide

Everything you need to know about the different COVID-19 vaccines, both already available and developing, in one place! Discover our…

Read More »

Iranian Blood Transfusion Organization Newsletter – December 2020

The Iranian Blood Transfusion Organization (IBTO) and its most recent activities are featured on TIF’S website.

Read More »

Blood Under The Microscope Of The European Commission: An Article by TIF’s Executive Director

by Dr Androulla Eleftheriou The European Commission published in October 2019 the Evaluation Report of the European legal framework for…

Read More »

THALIA App: The Skilled Digital Assistant of People with Thalassaemia and Sickle Cell Disease

Committed to continuing efforts to develop useful tools for individuals with thalassaemia and haemoglobin disorders worldwide, TIF introduces a novel…

Read More »

COVID-19 Vaccines and Haemoglobin Disorders: The Latest Position Statement of the Thalassaemia International Federation

In view of the plans made by national health authorities in every country across the world for the widespread vaccination…

Read More »

Virtual Delegation Visit to Sweden – 8 December 2020

Read More »

TIF & UNITED Onlus To Co-Host The 1st PanItalian Associations Meeting On New Therapies For Haemoglobinopathies

In light of the tremendous scientific developments in the field of thalassemia and sickle cell disease (SCD) with new drugs…

Read More »